Health&Life Co

Health&Life Co Total Assets

The Total Assets of Health&Life Co (1781.TWO) as of Oct 27, 2026 is 723.13 M TWD. In the previous year, Total Assets was 817.26 M TWD — a change of -11.52% (lower).

Total Assets

723.13 MTWD

YoY

-11.52%

Last updated:

Total Assets of Health&Life Co is 2025 723.13 M TWD. Total Assets of Health&Life Co was 2024 817.26 M TWD. It decreases by -11.52% lower compared to the previous year.

The Health&Life Co Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2018
596.24 M TWD
Jan 1, 2019
570.31 M TWD
Jan 1, 2020
1.01 B TWD
Jan 1, 2021
776.39 M TWD
Jan 1, 2022
799.76 M TWD
Jan 1, 2023
710.79 M TWD
Jan 1, 2024
817.26 M TWD
Jan 1, 2025
723.13 M TWD
The Health&Life Co Total Assets history
YEARTotal AssetsYoY
723.13 MTWD-11.52%
817.26 MTWD+14.98%
710.79 MTWD-11.12%
799.76 MTWD+3.01%
776.39 MTWD-23.05%
1.01 BTWD+76.92%
570.31 MTWD-4.35%
596.24 MTWD+3.95%
573.60 MTWD-10.63%
641.83 MTWD-7.77%
695.88 MTWD-16.98%
838.25 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Health&Life Co Stock analysis

What does Health&Life Co do? Health&Life Co Ltd generates revenue through the manufacturing and distribution of cardiovascular disease, in-vitro diagnostics, and respiratory care products. The company's primary products include electronic sphygmomanometers such as blood pressure monitors, nebulizers, and blood glucose monitoring systems, which measure and record systolic and diastolic blood pressure and glucose levels. These products are sold domestically in Taiwan and internationally to overseas markets. The firm targets healthcare providers, clinics, and consumers seeking home health monitoring solutions for chronic conditions like hypertension and diabetes. The company's product portfolio focuses on electronic sphygmomanometers, which are essential for daily health monitoring. By offering devices that measure blood pressure and glucose levels, Health&Life Co Ltd caters to patients managing cardiovascular and metabolic diseases. The domestic market in Taiwan serves as a key sales channel, while overseas markets provide additional growth opportunities for the firm's diagnostic and respiratory care products. Health&Life Co Ltd's business model relies on direct sales of medical devices to healthcare institutions and end-users. The firm's electronic sphygmomanometers, including blood pressure monitors and blood glucose systems, are distributed through both domestic and international channels. This approach ensures consistent revenue streams from the ongoing demand for home health monitoring equipment among patients with chronic conditions. Health&Life Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Health&Life Co stock

Total Assets of Health&Life Co is 723.13 M TWD in 2025.

Total Assets of Health&Life Co changed from 817.26 M TWD to 723.13 M TWD, representing a -11.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets Health&Life Co since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's Health&Life Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Health&Life Co

All Key Metrics — Health&Life Co